# Recent Publications on SARS2

1. **2020_05_Wherry_ImmuneProfiling_heterogeneity_immunotypes** <br>
[Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions](https://www.biorxiv.org/content/10.1101/2020.05.20.106401v1)

2. **2020_05_Betts_Immunologic_perturbations_severe_SARS2_infection** <br>
[Immunologic perturbations in severe COVID-19/SARS-CoV-2 infection](https://www.biorxiv.org/content/10.1101/2020.05.18.101717v1)

3. **2020_04_REVIEW_Renia_MacAry_Ng** <br>
[The trinity of COVID-19: immunity, inflammation and intervention](https://www.nature.com/articles/s41577-020-0311-8)

4. **2020_05_Chen_Reduction_Exhaustion_T_cell_COVID19** <br>
[Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)](https://www.frontiersin.org/articles/10.3389/fimmu.2020.00827/full?utm_source=fweb&utm_medium=nblog&utm_campaign=ba-sci-fimmu-covid-tcell-exhaustion)

5. **2020_05_Moore_June_Cytokin_release_syndrome_severe_COVID19** <br>
[Cytokine release syndrome in severe COVID-19](https://science.sciencemag.org/content/368/6490/473.summary?casa_token=ehTPupOPNfwAAAAA:eJFd-y3oIMw5MWOWhW5FQrq06_OdG0GMzD7fj1871E3g7ruc_mdsljQheEeDL3WuMikqslawmWyqtw)

6. **2020_05_Sette_Crotty_Targets_T_cell_response** <br>
[Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals](https://www.sciencedirect.com/science/article/pii/S0092867420306103?casa_token=7sN-sJVxhigAAAAA:ygqGpY0kx6gRWHKbP1xgf_dzi1nNgrwy_95p_Rjr8jos4b3w1ZTH_JTTKu6GNL4y5Ns6bv2fdg)

7. **2020_03_Tian_Dysregulation_Immune_COVID19_Wuhan** <br>
[Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa248/5803306)

8. **2020_03_Zheng_Elevated_exhaustion_levels_T_cell_blood_COVID19** <br>
[Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients](https://www.nature.com/articles/s41423-020-0401-3)

9. **2020_03_Tian_Functional_exhaustion_antiviral_lymphocytes_COVID19** <br>
[Functional exhaustion of antiviral lymphocytes in COVID-19 patients](https://www.nature.com/articles/s41423-020-0402-2)

10. **2020_03_REVIEW_Melino_COVID19_perspective_immune_response** <br>
[COVID-19 infection: the perspectives on immune responses](https://www.nature.com/articles/s41418-020-0530-3?fbclid=IwAR2ZxeCwG6GQEZTC1GQbizfu0d5i1wqIREmK5IKRgeR2TsUc1dg8ta1GYyA)

11. **2020_03_Xu_Digestive_system_COVID19_single_cell** <br>
[Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process](https://gut.bmj.com/content/69/6/1010.abstract)

12. **2020_02_Zhang_lung_brochoalveolar_immune_cell_COVID19_single_cell** <br>
[Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19](https://www.nature.com/articles/s41591-020-0901-9)

13. **2020_05_Wang_Immune_cell_profiling_COVID19_recovery_stages_single_cell** <br>
[Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing](https://www.nature.com/articles/s41421-020-0168-9)

14. **2020_04_Wedtner_Virological_accessment_hosptalized_COVID19** <br>
[Virological assessment of hospitalized patients with COVID-2019](https://www.nature.com/articles/s41586-020-2196-x)

15. **2020_05_Haagmans_Comparative_pathogenesis_COVID19_MERS_SARS_non_human_primate** <br>
[Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model](https://science.sciencemag.org/content/368/6494/1012)

16. **2020_04_tenOver_Imbalanced_host_response_COVID19** <br>
[Imbalanced Host Response to SARS-CoV-2 Drives
Development of COVID-19](https://www.sciencedirect.com/science/article/pii/S009286742030489X)

17. **2020_05_REVIEW_Gack_Dysregulation_type_I_inteferon_response_COVID19** <br>
[Dysregulation of type I interferon responses in COVID-19](https://www.nature.com/articles/s41577-020-0346-x)

18. **2020_07_REVIEW_Sette_Crotty_Pre-existing_immunity_SARS2** <br>
[Pre-existing immunity to SARS-CoV-2: the knowns and unknowns](https://www.nature.com/articles/s41577-020-0389-z)

19. **2020_07_Wheatley_Humoral_circulating_Tfh_recovered_COVID19** <br>
[Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19](https://www.nature.com/articles/s41591-020-0995-0)

20. **2020_07_Thiel_SARS2_reactive_T_cell_healthy_donor_patient** <br>
[SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19](https://www.nature.com/articles/s41586-020-2598-9)

21. **2020_07_Bertoletti_SARS2_specific_T_cell_immunity_COVID19_SARS_uninfected** <br>
[SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls](https://www.nature.com/articles/s41586-020-2550-z)

22. **2020_07_Lu_Viral_host_factors_clinical_outcome_COVID19** <br>
[Viral and host factors related to the clinical outcome of COVID-19](https://www.nature.com/articles/s41586-020-2355-0)

23. **2020_04_NEWS_How_COVID19_kill_uncertainty_treatments** <br>
[How does COVID-19 kill? Uncertainty is hampering doctorsâ€™ ability to choose treatments](https://www.nature.com/articles/d41586-020-01056-7)

24. **2020_08_Chen_Acute_SARS2_infection_impairs_dendritic_cell_T_cell_response** <br>
[Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses](https://linkinghub.elsevier.com/retrieve/pii/S1074761320303332)

25. **2020_08_Sander_Severe_COVID19_dysregulated_myeloid_cell_compartment** <br>
[Severe COVID-19 is marked by a dysregulated myeloid cell compartment](https://doi.org/10.1016/j.cell.2020.08.001)

26. **2020_08_Ma_Learning_model_evaluate_hospitalization_priority_COVID19** <br>
[A Learning-based Model to Evaluate Hospitalization Priority in COVID-19 Pandemics](https://doi.org/10.1016/j.patter.2020.100092)

27. **2020_07_Alter_Distinct_early_serological_signatures_SARS2_survival** <br>
[Distinct early serological signatures track with SARS-CoV-2 survival](https://linkinghub.elsevier.com/retrieve/pii/S1074761320303277)

28. **2020_07_Nemati_ML_approaches_COVID19_survival_discharge_time_prediction** <br>
[Machine-Learning Approaches in COVID-19 Survival Analysis and Discharge-Time Likelihood Prediction Using Clinical Data](https://doi.org/10.1016/j.patter.2020.100074)

29. **2020_06_Liu_Single_cell_sequencing_PB_mononuclear_cell_distinct_immune_response_COVID19** <br>
[Single-cell sequencing of peripheral blood mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients](https://linkinghub.elsevier.com/retrieve/pii/S1074761320303162)

30. **2020_07_He_DL_early_triage_critically_ill_COVID19_patients** <br>
[Early triage of critically ill COVID-19 patients using deep learning](https://www.nature.com/articles/s41467-020-17280-8)

31. **2020_08_Weiskopf_Sette_Selective_cross_reactive_SARS2_T_cell_epitopes** <br>
[Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans](https://science.sciencemag.org/content/early/2020/08/04/science.abd3871)

32. **2020_07_Wherry_Deep_immune_profiling_COVID19_distinct_immunotypes** <br>
[Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications](https://science.sciencemag.org/content/early/2020/07/15/science.abc8511)

33. **2020_08_Terrier_impaired_type_I_interferon_inflammatory_severe_COVID19** <br>
[Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients](https://science.sciencemag.org/content/369/6504/718)

34. **2020_08_Wack_Type_1_3_interferons_disrupt_lung_epithelial_repair_viral_infection** <br>
[Type I and III interferons disrupt lung epithelial repair during recovery from viral infection](https://science.sciencemag.org/content/369/6504/712)

35. **2020_08_Zanoni_Type_3_interferon_disrupt_lung_epithelial_barrier** <br>
[Type III interferons disrupt the lung epithelial barrier upon viral recognition](https://science.sciencemag.org/content/369/6504/706)
